The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Lanying Du(New York Blood Center), Yuxian He(New York Blood Center), Yusen Zhou(Institute of Microbiology), Shuwen Liu(Southern Medical University), Bo-Jian Zheng(University of Hong Kong), Shibo Jiang(New York Blood Center)
Cited by 1,768Open Access
Abstract
Related Papers
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
Jianhua Sui, Wenhui Li, Akikazu Murakami et al.|Proceedings of the National Academy of Sciences|2004|581